State Street Health Care Select Sector SPDR ETFXLV
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −0.1% | +9.9% | +10.1% | +20.9% | +29.0% | +55.7% | +49.8% | +688.4% |
| Peer average | +0.8% | +5.8% | +2.9% | +20.5% | +29.5% | +75.3% | +27.5% | — |
| S&P 500 · VOO | +0.3% | −5.0% | −4.6% | +8.7% | +9.8% | +80.8% | +71.8% | — |
XLV in One Breath
XLV Among Health Care ETFs
YTDEnd-of-day Nov 8, 2026 · 33 Health care ETFs by YTD
$10,000 in XLV
5Y$10,000 in XLV became
$14,979
In the S&P 500 (VOO)
$17,177
Total return, dividends in · Oct 29, 2021 – Nov 6, 2026 · S&P 500 uses VOO
XLV’s Top Holdings
TodayLLYEli Lilly +16.3%JNJ9.8%ABBV7.6%MRK5.4%UNH5.3%TMO3.7%AMGN3.7%GILD3.1%ABT2.9%PFE2.5%ISRG2.5%DHR2.1%VRTX2.1%BMY1.9%MDT1.9%MCK1.9%SYK1.7%CVS1.6%ELV1.4%MRNAREGNCI39 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
SPDR XLV · 61 holdings · tile size = share of the fund · as of Nov 6, 2026
What XLV Holds
TodayDrug Manufacturers - General50.9%
LLY 16.3 · JNJ 9.8 · ABBV 7.6 · MRK 5.4 · AMGN 3.7 · GILD 3.1 · PFE 2.5
Medical - Diagnostics & Research11.0%
TMO 3.7 · DHR 2.1 · IDXX · A · WAT · IQV · MTD
Medical - Healthcare Plans10.7%
UNH 5.3 · CVS 1.6 · ELV 1.4 · CI 1.2 · HUM · CNC
Medical - Devices10.1%
ABT 2.9 · MDT 1.9 · SYK 1.7 · BSX · EW · GEHC · DXCM
Biotechnology5.2%
VRTX 2.1 · MRNA 1.3 · REGN 1.3 · INCY · TECH
Medical - Instruments & Supplies4.8%
ISRG 2.5 · BDX · RMD · WST · BAX · SOLV · COO
Medical - Distribution3.9%
MCK 1.9 · COR · CAH · HSIC
SPDR XLV · share of the fund by industry · as of Nov 6, 2026
Eli’s Share of XLV
Today16.3%
$163 of every $1,000 in XLV is Eli
Eli held by XLV
$8.1B
SPDR XLV · each square = $10 of $1,000 · as of Nov 6, 2026
XLV’s Share of Health Care ETFs
Today45.4%
of the $110B in 39 Health care ETFs
$49.9B45.4%
$19.1B17.3%
$10.0B9.1%
$31.0B28.2%
Health care ETF AUM · Nov 8, 2026
XLV Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 8, 2026
Inside XLV
61 holdings · as of Nov 6, 2026XLV
State Street Health Care Select Sector SPDR ETF
TodayDrug Manufacturers - General50.9%LLYELI Lilly +16.3%JNJ9.8%ABBV7.6%MRK5.4%AMGN3.7%GILD3.1%PFEBMYBIIBMedical - Diagnostics11.0%TMO3.7%DHRIDXXAWATIQVMTDILMNMedical - Healthcare Plans10.7%UNH5.3%CVSELVCIHUMCNCMedical - Devices10.1%ABTMDTSYKBSXEWDXCMZBHBiotechnology5.2%VRTX2.1%MRNAREGNMedical - Instruments4.8%ISRGBDXRMDMedical - Distribution3.9%MCKCORCAHHCAZTSVEEVSTE
Drug Manufacturers - General50.9%LLY16.3%JNJ9.8%ABBV7.6%MRK5.4%AMGNGILD3 moreMedical - Diagnostics11.0%TMODHRIDXXAWAT6 moreMedical - Healthcare Plans10.7%UNH5.3%CVSELVCIHUMCNCMedical - Devices10.1%ABT2.9%MDTSYKBiotechnology5.2%VRTXMRNAREGNMedical - Instruments4.8%ISRGBDXMedical - Distribution3.9%MCKCORCAHHCAVEEV
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly + | 16.30% |
| 2 | JNJ | Johnson + Johnson | 9.79% |
| 3 | ABBV | Abbvie | 7.60% |
| 4 | MRK | Merck + | 5.41% |
| 5 | UNH | Unitedhealth Group | 5.30% |
| 6 | TMO | Thermo Fisher Scientific | 3.74% |
| 7 | AMGN | Amgen | 3.71% |
| 8 | GILD | Gilead Sciences | 3.10% |
| 9 | ABT | Abbott Laboratories | 2.93% |
| 10 | PFE | Pfizer | 2.51% |
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsMedical - DistributionMedical - Care FacilitiesDrug Manufacturers - SpecialtySoftware - ApplicationMedical - SpecialtiesOther
SPDR XLV · current holdings by weight · as of Nov 6, 2026 · each tile is one holding · top 20 = 78.8%
All XLV Holdings
64 holdings · as of Nov 6, 2026XLV
XLV’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly + | Healthcare | 16.30% | $1,629.78 | 5.9M | $8.10B |
| 2 | JNJJohnson + Johnson | Healthcare | 9.79% | $979.46 | 17.9M | $4.87B |
| 3 | ABBVAbbvie | Healthcare | 7.60% | $760.20 | 13.1M | $3.78B |
| 4 | MRKMerck + | Healthcare | 5.41% | $541.06 | 18.3M | $2.69B |
| 5 | UNHUnitedhealth Group | Healthcare | 5.30% | $530.13 | 6.7M | $2.63B |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.74% | $373.57 | 2.7M | $1.86B |
| 7 | AMGNAmgen | Healthcare | 3.71% | $371.39 | 4.0M | $1.84B |
| 8 | GILDGilead Sciences | Healthcare | 3.10% | $310.11 | 9.2M | $1.54B |
| 9 | ABTAbbott Laboratories | Healthcare | 2.93% | $293.38 | 12.8M | $1.46B |
| 10 | PFEPfizer | Healthcare | 2.51% | $250.52 | 42.3M | $1.24B |
| 11 | ISRGIntuitive Surgical | Healthcare | 2.47% | $247.03 | 2.6M | $1.23B |
| 12 | DHRDanaher | Healthcare | 2.11% | $211.35 | 4.6M | $1.05B |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 2.05% | $205.22 | 1.9M | $1.02B |
| 14 | BMYBristol Myers Squibb | Healthcare | 1.92% | $192.47 | 15.1M | $956.1M |
| 15 | MDTMedtronic | Healthcare | 1.92% | $191.54 | 9.1M | $951.5M |
SPDR XLV · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 6, 2026
How It Compares
XLV
State Street Health Care Select Sector SPDR ETF’s Peers
1YHealth care peers · Past-year and ytd returns · as of Nov 9, 2026 · sorted by AUM
Head to Head
Put XLV head to head with VHT →VHT vs XLV
YTDYear to date
XLV wins+1.1 pts
Past year
XLV wins+1.6 pts
Fee
XLV winslower fee
Yield
Level
AUM
XLV2.6× more
3–0XLV wins
Vanguard VHT and SPDR XLV · year-to-date · as of Nov 9, 2026 · AUM not scored
XLV vs VOO
1YXLV · Health Care Select Sector SPDR
+29.0%
VOO · S&P 500
+9.8%
Gap
19.2 pts
SPDR XLV and Vanguard VOO · 1Y total return · as of Nov 9, 2026
XLV vs Its Peer Average
YTDXLVAvsBPeer average
1D−0.1%+0.8%
1M+9.9%+5.8%
3M+10.1%+2.9%
YTD+20.9%+20.5%
1Y+29.0%+29.5%
3Y+55.7%+75.3%
5Y+49.8%+27.5%
4–3XLV wins
38 Health care peers · each row scaled to its leader
How Bumpy Is XLV?
ViewXLV
How Bumpy
1Y1.2×the S&P 500’s swings
CalmerBumpierS&P 1×XLV
Calm rank among 7 health care funds#4
Other health care funds1.2× to 2.2×
SPDR XLV · daily swings over the past year vs the S&P 500
XLV
Worst Drop
1Y−10.5%from its Feb 27 high
Still below the high−2.6%
$10,000 at the high is now$9,740
SPDR XLV · fall from the highest close, past year
XLV
On a Bad Day
1Y0.1×the S&P 500’s fall
XLV’s worst day: Tuesday, Sep 8Up days47 of every 100
S&P 500 up days52 of every 100
SPDR XLV · average move on days the S&P 500 fell
XLV
Return for the Bumps
1Y#1 of 7 health care fundsRanked by return above cash for each unit of bumpiness (Sharpe ratio) · cash = 3.8%
XLV
Cost
Today$8a year per $10,000
Expense ratio 0.08%, taken from the fund’s value
XLV
Volatility & Beta
1Y16.8%annual volatility
S&P 500 volatility13.6%
Downside volatility9.9%
Beta vs SPY0.29
Correlation vs SPY0.23
Lowest beta of 7 health care fundsXLV
Daily total returns × √252 · past 254 trading days
XLV
Max Drawdown
1Y−10.5%peak to trough
Peak closeFeb 27, 2026
Current drawdown−2.6%
Worst day−2.52% · Sep 8
Closing prices, dividends in
XLV
Up / Down Capture
1Y7%down capture vs SPY
Up ÷ down capture5.33
Up days47.2% (S&P 52.0%)
Average daily move on SPY up days and down days
XLV
Sharpe & Sortino vs Peers
1YSharpe = (return − 3.8% cash) ÷ volatility · Sortino uses downside volatility only
XLV
Trading
Today−0.05%below its holdings’ value
Close$184.80
NAV$184.90
Fee per $10,000$8 a year
Avg. volume 30D10.4M shares
Close vs net asset value, Nov 6
The Details
XLV
Fund Facts
Today1998launched Dec 16
Tracks[…]
Exchange · CUSIPAMEX · 81369Y209
StructureETF
Leverage1x
Cost on $10,000$8 a year
Go deeper
SPDR XLV · fund facts · as of Nov 9, 2026
XLV
Payouts by Year
13Y$0.64per share, Sep 2026
Distribution yield1.4%
PaidEvery quarter
Latest ex-date · paidSep 21 · Sep 23, 2026
12 payouts added up$7.26 a share
SPDR XLV · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-06-30 ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-06-30 ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗SEC reported portfolio · 2024-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-09-30 ↗SEC reported portfolio · 2023-06-30 ↗SEC reported portfolio · 2023-03-31 ↗SEC reported portfolio · 2022-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-06-30 ↗SEC reported portfolio · 2022-03-31 ↗SEC reported portfolio · 2021-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-09-30 ↗SEC reported portfolio · 2021-06-30 ↗SEC reported portfolio · 2021-03-31 ↗SEC reported portfolio · 2020-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-09-30 ↗SEC reported portfolio · 2020-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2019-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2019-09-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$184.90
Premium / discount[…]
Median spread · 30D[…]
Volume today15.0M
Average volume · 30D10.4M
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.08%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$8.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.64 |
| Jun 22, 2026 | Jun 24, 2026 | $0.66 |
| Mar 23, 2026 | Mar 25, 2026 | $0.59 |
| Dec 22, 2025 | Dec 24, 2025 | $0.66 |
| Sep 22, 2025 | Sep 24, 2025 | $0.62 |
| Jun 23, 2025 | Jun 25, 2025 | $0.63 |
| Mar 24, 2025 | Mar 26, 2025 | $0.56 |
| Dec 23, 2024 | Dec 26, 2024 | $0.62 |
| Sep 23, 2024 | Sep 25, 2024 | $0.58 |
| Jun 24, 2024 | Jun 26, 2024 | $0.57 |
| Mar 18, 2024 | Mar 21, 2024 | $0.52 |
| Dec 18, 2023 | Dec 21, 2023 | $0.60 |
Issuer contentFrom SPDRHear the strategy from the people behind XLV.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →